Physician profile
Jonathan Meyer
NPI 1285021758
$21,653.99
in general payments reported to CMS, 2019-2025
36 companies · $7,238 in 2025
The $7,238 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $254 · 2021: $565 · 2022: $5,483 · 2023: $2,774 · 2024: $5,341 · 2025: $7,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $5,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,288.83 |
| Travel and Lodging | $5,062.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,988.01 | 2021-2025 | Corevalve Evolut R, Turbohawk, Onyx Frontier |
| Boston Scientific Corporation | $4,248.33 | 2022-2025 | General - Vascular Access, Avvigo Guidance System, General - Therapies |
| Philips North America LLC | $1,933.92 | 2023-2025 | (Bq9) Coronary Ivus, Coronary Other, (Ck7) Extended Holter |
| Edwards Lifesciences Corporation | $666.39 | 2024-2025 | Sapien 3 Ultra Resilia, Evoque |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $632.34 | 2020-2025 | Lifevest |
| Abiomed | $624.83 | 2022-2025 | Impella |
| Acist Medical Systems, INC. | $608.49 | 2023-2025 | |
| Abbott Laboratories | $449.34 | 2022-2025 | Cardiomems |
| Biotronik INC. | $398.12 | 2024-2025 | Trapit, Recross, Pantera Leo |
| Teleflex LLC | $392.95 | 2025 | Turnpike, Guideliner, Orsiro Mission |
| Novartis Pharmaceuticals Corporation | $366.05 | 2021-2025 | Leqvio |
| Shockwave Medical, INC | $249.15 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| United Therapeutics Corporation | $222.26 | 2024 | |
| Penumbra, INC. | $200.32 | 2023 | Indigo System |
| Angiodynamics, INC. | $164.44 | 2023 | Alphavac |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $147.68 | 2022-2025 | Cleviprex, Kengreal |
| Inspire Medical Systems, INC. | $137.97 | 2023-2024 | Inspire |
| Cardiovascular Systems INC. | $129.27 | 2020 | |
| W. L. Gore & Associates, INC. | $115.63 | 2022-2025 | Gore Viabahn Endoprosthesis |
| Endotronix, INC. | $107.49 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Ge Healthcare | $100.21 | 2022 | |
| Amgen INC. | $97.58 | 2024-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $88.71 | 2021 | |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Inari Medical, INC. | $82.87 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $82.32 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $68.31 | 2022-2023 | Xarelto |
| Scpharmaceuticals INC. | $53.11 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $42.59 | 2021-2025 | Farxiga |
| Abbvie INC. | $34.64 | 2021 | |
| Recor Medical INC | $31.44 | 2025 | Paradise Ultrasound Renal Denervation System |
| Surmodics, INC. | $29.79 | 2025 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Merck Sharp & Dohme LLC | $22.31 | 2023 | Verquvo |
| Atricure, INC. | $18.69 | 2024 | |
| Terumo Medical Corporation | $17.82 | 2023 | Heartrail, Glidewire |
| Cordis US Corp. | $16.50 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.